These 10 multibaggers are off to a flying start in 2020 after tepid 2019

NEW DELHI: After facing a rough patch in 2019, 10 multibagger stocks are off to a flying start in 2020. These stocks have jumped 14-43 per cent so far in 2020 after clocking negative returns for the previous year. For long-term investors, these stocks have delivered anywhere between 1,000 per cent and 22,300 per cent returns in last 10 years.

These multibaggers included Ajanta Pharma. The stock fell 18 per cent in 2019 only to jump 43 per cent in 2020, taking its 10-year gains to a whopping 6,341 per cent.

La Opala RG is up 32 per cent in 2020 so far after falling 33 per cent for the previous year. This stock jumped 4,500 per cent in last 10 years. Shares of Garware Technical Fibres, which were flat last year, are up 30 per cent this calendar. This stock gained 2,600 per cent in last one decade.

Caplin Point Laboratories’ 10-year return is mindboggling at 22,300 per cent. This stock has gained 23 per cent after falling 21 per cent in 2019.

Shares of Natco Pharma have gained 20.42 per cent year to date after falling 13 per cent in 2019, Supreme Industries and Solar Industries have gained 20 per cent each after falling 2 per cent each in the previous year. These stocks have gained 1,200-2,700 per cent in last 10 years.


Other multibaggers VIP Industries, Aegis Logistics and Bombay Burmah Trading Corporation have gained 14-17 per cent in 2020 after a poor 2019. Analysts are positive on a few of these names.

Rough patch for most of these 10 stocks in fact lasted more than a year. In addition to 2019's fall, Ajanta Pharma was down 20 per cent in 2018 and 16 per cent in 2017. La Opala RG was down 28 per cent in 2018. Natco Pharma had fallen 29 per cent in 2018. Caplin was also down 39 per cent in 2018.

On Ajanta Pharma, Motilal Oswal Securities said: “After two years of earnings decline, Ajanta Pharma’s earnings growth is back on track, led by superior execution in India/Asia/Africa branded generics segment that accounts for 67 per cent of sales and healthy traction in new ANDA launches. Further, new orders from institutional agencies should also support sales as well as profitability.”

Axis Securities remains positive on VIP Industries, estimating VIP’s sales and profit growth of 12 per cent and 24 per cent over FY19-FY22.

“Scaling up of Bangladesh operations, strong bargaining power with Chinese vendors for sourcing of luggage and efficient inventory management will lead to improvement in working capital efficiencies and also Ebitda margins expansion f 300 basis points to 15.6 per cent by FY22,” it said justifying premium valuations.

Strong performance, Kotak Securities said, compelled the brokerage to continue to recommend BUY rating on Aegis Logistics last week, with an increased target of Rs 285 from Rs 260), valuing the stock 24 times FY22 earnings.

Analysts also like Natco Pharma.

“If you look at the entire pharma space what we have been bullish has been on companies which have got significant business in India. If there is a significant growth happening in the domestic pharmaceutical industry, a stock like Torrent pharma or Natco Pharma can definitely be looked at,” Sudip Bandyopadhyay, Inditrade Capital told ET NOW recently.